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Abstract 1 
This study compares the effects of two resistance training programs in peripheral and 2 
respiratory musculature on muscle mass and strength and physical performance, and identify 3 
the appropriate muscle mass parameter for assessing the intervention effects. Thirty-seven 4 
institutionalized older Spanish adults with sarcopenia were analyzed: Control Group (n=17), 5 
Respiratory Muscle Training Group (n=9) and Peripheral Muscle Training Group (n=11). Pre 6 
and post-intervention, participants were assessed for Appendicular Skeletal Mass 7 
(ASM/height2; ASM/weight; ASM/BMI), isometric knee-extension, arm-flexion and handgrip 8 
strength, Inspiratory and Expiratory Maximal Pressures (MIP and MEP), and gait speed. 9 
Trained groups participated in a 12-week program and improved in MIP, MEP, knee-10 
extension and arm-flexion (p<.05), while nonsignificant changes were showed in gait speed 11 
and ASM indexes between pre and post-intervention in the three groups. In conclusion, 12 
resistance training improved skeletal muscle strength in the studied population, and any ASM 13 
index was found to be appropriate in detecting changes after physical interventions. 14 
 15 
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The presence of comorbidity and other factors such as physical inactivity in older 1 
people favor the onset of sarcopenia (Cruz-Jentoft et al., 2010). The prevalence of this 2 
geriatric syndrome in institutionalized older adults is around 14-33% in Europe (Cruz-Jentoft 3 
et al., 2014), and even higher in Spain (37%) (Salvà et al., 2016).  4 
The European Working Group on Sarcopenia in Older People (EWGSOP) defines this 5 
syndrome as a gradual and widespread loss of skeletal muscle mass and strength. As a result, 6 
mobility disorders appear, such as an increased risk of falls and fractures, impaired ability to 7 
perform daily living activities, loss of independence, a worsening of comorbidity and an 8 
increased risk of death (Cruz-Jentoft et al., 2010). Recently, the International Working Group 9 
on Sarcopenia (IWGSP) and Asian Working Group for Sarcopenia (AWGSP) shared this 10 
definition but both groups suggested working towards a more appropriate selection of 11 
diagnostic cut-off values (Wei-Ju, Li-Kuo, Li-Ning, Ming-Hsien & Liang-Kung, 2013; Chen 12 
et al., 2014). In this respect, recent studies (Meng et al., 2015; Ethgen et al., 2016; Kim et al., 13 
2016) emphasize the need to personalize the cut-off values according to the characteristics of 14 
the studied population (anthropometrics, ethnic and clinical setting).  15 
Previous literature points out that this loss affects the skeletal muscles involved in both 16 
mobility (limb or peripheral muscles, PMs) and ventilation (respiratory muscles, RMs). 17 
Enright et al. (1994) and Neder et al. (1999) corroborate the association between the strength 18 
of the PMs and RMs. In studies of institutionalized older adults, the prevalence of decreased 19 
strength of the PMs and RMs is clear (Simões, Castello, Auad, Dionísio & Mazzonetto, 2009; 20 
Simões, Dias, Marinho, Pinto & Britto, 2010; Cruz-Jentoft et al., 2010). Authors such as 21 
Newman et al. (2003) suggest that during aging the decline in lower limb muscle strength is 22 
greater than in upper limbs, and is associated with lower gait speed and increased risk of 23 
disability. Moreover, dysfunction of the RMs is accompanied by a reduced tolerance 24 
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requirement associated with the basic activities of daily living, and in some extreme cases 1 
with respiratory failure (Bahat et al., 2014).  2 
In addition, most Systematic Reviews and Meta-Analysis for Sarcopenia in older 3 
adults (Cruz-Jentoft et al., 2014; Beaudart, Zaaria, Pasleau, Reginster & Bruyère, 2017) 4 
suggest exercise interventions (mainly resistance exercises) can improve muscle strength and 5 
physical performance, with the majority of these studies being carried out in older adults 6 
living in the community. In this respect, it is worth considering extending the research to 7 
older adult groups living in other settings, such as hospitals and nursing homes. Currently, 8 
studies show high prevalence of sarcopenia in older adults residing in nursing homes (Landi 9 
et al., 2012; Henwood, Keogh, Reid, Jordan & Senior, 2014) and initial results regarding 10 
resistance training on sarcopenia in nursing care facilities are emerging. These are mainly 11 
focused on the improvement in the strength of only the peripheral muscles (Hassan et al., 12 
2016) or of the respiratory muscles (Cebrià i Iranzo, Arnall, Igual Camacho, Tomás & 13 
Meléndez, 2013), but there is a lack of studies which compare both resistance training 14 
interventions.  15 
It is assumed that the physical intervention in the institutionalized older adults is 16 
accompanied by lower benefits (Cruz-Jentoft et al., 2011). The clinical novelty of this study is 17 
showing that resistance exercise interventions in nursing homes may improve, or at least 18 
control, the deterioration that sarcopenia entails in older adults, as well as reduce the risk of 19 
mortality associated to muscle strength (Newman et al., 2006). On the other hand, it 20 
highlights the use of this exercise intervention as a routine in the socio-sanitary planning of 21 
nursing homes.  22 
In light of the above, and considering the importance of preventing sarcopenia effects 23 
in institutionalized older people, the main objective of this study was to compare the effects of 24 
two resistance training programs in peripheral and respiratory musculature on muscle mass 25 
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and strength and physical performance. And a secondary objective was to compare and 1 
identify which parameters relative to muscle mass are the appropriate for assessing the effects 2 
of resistance training programs in institutionalized older adults in Spain. We hypothesize that 3 
resistance training would improve muscle mass and strength, and physical performance in 4 
older adults with sarcopenia, although these effects would depend on the specific resistance 5 
training program (PM or RM training).  6 
Method 7 
Study design 8 
This study was designed as a parallel group randomized controlled trial in which 81 9 
institutionalized older Spanish adults with sarcopenia were randomized on a single sequence 10 
(simple randomization) to one of three balanced groups: One Control Group (CG) and two 11 
resistance training groups (Peripheral Muscle Training Group (PMTG) and Respiratory 12 
Muscle Training Group (RMTG)). A flow diagram (Figure 1) describes the participant 13 
eligibility, randomization, lost to follow-up and data analysis. A statistician who had no 14 
contact with the participants and/or the health care professionals who undertook the 15 
measurements and the intervention performed the random allocation sequence (random 16 
number generator in SPSS; SPSS, Inc, Chicago, Illinois). The three groups were followed in 17 
the same way and the only difference between them was the received care. CG participants 18 
obtained standard treatment and were asked to maintain their usual care and daily life 19 
activities at the nursing home (lying down, sitting, and walking short distances between 20 
rooms). Participants of the intervention groups (PMTG and RMTG) also carried out a 21 
resistance training program for 12 weeks.  22 
INSERT FIGURE 1 ABOUT HERE 23 
The University of XXXX Ethics Committee for Human Research (H1382044172319) 24 
approved this study. All participants were informed of the risks and benefits, and agreed to 25 
RESISTANCE TRAINING IN SARCOPENIC OLDER ADULTS  6
participate by signing a consent form. This study was performed between 2013 and 2016, and 1 
has been registered in the ClinicalTrials.gov (NCT ID: NCT02120586). 2 
Participants  3 
The sample was made up of all eligible older adults from four nursing homes located 4 
in XXXX, Spain. The nursing homes involved met similar criteria in relation to classification 5 
of the participants and had similar professional health services. Participants met the following 6 
inclusion criteria: (1) Older than 65 years; (2) clinically stable at least two months before the 7 
study; and (3) compliance of the sarcopenia diagnostic criteria proposed by Tyrovolas et al. 8 
(2015) which include: (a) Skeletal Muscle Mass Index (SMI = Appendicular Skeletal Muscle 9 
Mass/Body Mass Index) with cut-off points for Spanish population ( ≤ 0.93 for male and  ≤ 10 
0.57 for female)  and (b) gait speed  with cut-off points according to sex, height and age 11 
(between 0.95-0.66 m/s for male and 0.80-0-48 m/s for female). Exclusion criteria were as 12 
follows: (1) Those clinical situations (signs and/or symptoms) that could interfere in the 13 
proper performance of assessment and/or training protocols (i.e.: presence of edema or severe 14 
disorder of hydration status that could interfere in Bioelectrical Impedance Analysis 15 
(Rubbieri, Mossello, & Di Bari, 2014), malnutrition, muscle-joint pain, tremor or dyspnea at 16 
rest, recent fracture or surgery, etc.); (2) a terminal disease diagnosis; and (3) moderate or 17 
severe cognitive deterioration that could affect their proper collaboration (Mini-Mental State 18 
Examination score ≤ 20 points) (Lobo, Saz, & Marcos,  2002). 19 
Measurements  20 
Participants were assessed at enrollment phase (T1), after a 2-week familiarization 21 
(T2, baseline or pre-intervention) and at 12 weeks (T3, post-intervention). The reason for 22 
repeating two close assessments (T1 and T2) was to avoid the possible learning effect of tests. 23 
These assessments were conducted by researchers who were trained in the procedures by an 24 
expert before the data collection period and who were blind to the purpose of the study and 25 
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the participants’ group membership. Tests were performed over two consecutive days to 1 
avoid participant fatigue and to get the highest value.  2 
Outcomes and Procedures 3 
Each time-point measurements (T1-T3) recorded the following outcomes: 4 
Skeletal Muscle Mass. Bioimpedance Analysis (BIA) technique was used to assess muscle 5 
mass (Kg) using a Bodystat® 1500MDD (Bodystat Ltd., Douglas, Isle of Man, UK). 6 
Measurements were obtained under recommended standard conditions (NIH, 1996): 7 
participants in supine position on their bed, on waking up and with an empty stomach, upper 8 
and lower limbs of predominant side abducted at least 30-degree angle from the medium line, 9 
and controlled bedroom temperature of 25 degree. The equipment calibration, individual data 10 
introduction (sex, age, height and weight) and skin preparation for the placement of the 11 
adhesive electrodes on the wrist and the ankle of the predominant side were prepared 12 
previously. According to Meng et al. (2015) and Kim, Jang & Lim (2016) the skeletal mass 13 
index was defined as Appendicular Skeletal Muscle Mass (ASM), after being adjusted in 14 
different ways: height (ASM/height2), weight (ASM/weight) or Body Mass Index 15 
(ASM/BMI). 16 
Peripheral Muscle Strength. Maximal isometric muscle strength (Kg) was assessed with the 17 
dynamometer MicroFet 2® (Hoggan Health industries, West Jordan, UT, USA) on the 18 
predominant side for three consecutive trials with at least a 1 minute resting period between 19 
them. Previous strength testing, a 5-minute warm-up for lower and upper limbs on the 20 
Monark® Rehab Ergometer Trainer (Monark 881E; Vansbro, Sweden) was performed. 21 
Participants remained in a seated position with the muscle to be evaluated in relative 22 
shortening position, maintaining a maximal and sustained contraction for at least 3 seconds. 23 
The movements tested were: knee-extension (Quadriceps Femoris) and elbow-flexion (Biceps 24 
Brachii) (Bean et al., 2002). 25 
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The maximal handgrip strength (Kg) was measured with a hydraulic hand 1 
dynamometer Jamar Plus+® (Patterson Medical, Sammons Preston, Bolingbrook, IL, USA). 2 
Participants remained seated, the dynamometer in the dominant hand, with the elbow locked 3 
at 90º and at their side. Predicted values (%) for handgrip strength were also registered (Luna-4 
Heredia, Martín-Peña & Ruiz-Galiana, 2005). Three consecutive measurements were made on 5 
the predominant side upper limb with a between-measurement interval of 1 minute.  6 
Respiratory Muscle Strength. Maximum static inspiratory pressure (MIP, cmH2O) and 7 
maximum static expiratory pressure (MEP, cmH2O) were measured using a MicroRPM
® 8 
(Respiratory Pressure Meter, CareFusion, Hoechberg, Germany) according to the Black & 9 
Hyatt technique (1969). These strength measurements followed the standard guidelines 10 
established by the ATS/ERS Statement on respiratory Muscle Testing (2002). Predicted 11 
values (%) for both MIP and MEP were also registered by using the reference values reported 12 
by Enright, Kronmal, Manolio, Schenker & Hyatt (1994). 13 
For peripheral and respiratory muscle strength data, the highest value was recorded. 14 
Respiratory Muscle Endurance. Maximum Voluntary Ventilation test (MVV, L/min) was 15 
measured following the standard guidelines established by the ATS/ERS Statement on 16 
respiratory Muscle Testing (2002), using a portable Jaeger® spirometer as referred to above.  17 
Physical Performance. Maximal gait speed (m/s) was collected as participants walked as fast 18 
as they safely could on a marked 14 m walkway. Participants started and finished walking two 19 
meters before and after the walkway to ensure the participants reached a steady state gait 20 
speed across the middle 10 meters (Tilson et al., 2010). Each participant performed two 21 
consecutive trials with a one minute resting period between them, and the highest value was 22 
recorded. Pulse oximetry was registered during the test and the participants were asked about 23 
their subjective effort perception by the Borg CR10 Scale (Borg, 2004). 24 
Interventions  25 
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Both intervention groups participated in a 12-week training program, three times a 1 
week on alternate days, in groups of eight to ten participants. All training sessions were 2 
supervised by two physiotherapists not involved in assessments (T1-T3). Previously, 3 
familiarization consisted of six sessions to guarantee appropriate realization was performed 4 
with low training workload (5-10% of maximal muscle strength (Kg) for PMTG and 7-9 5 
cmH2O for RMTG). Since some of the participants could not remain standing, the training 6 
was performed in a sitting position. Each session was structured in four phases: (1) Record of 7 
resting blood pressure, heart frequency and oxygen saturation (SpO2); (2) an initial 5-minutes 8 
warm-up; (3) resistance exercises with workload during 20 to 30 minutes; and (4) a final 5-9 
minute cool-down to recover baseline condition. Individual training journals were kept on the 10 
progress of each participant documenting the increases in training workload as well as 11 
recording their perceived exertional efforts (Borg CR10 Scale) and any complaints related to 12 
training program reported by the participants. In order to ensure that each participant was 13 
training with the appropriate workload, a monthly measurement was performed. Participants 14 
who attended less than 80% of the sessions in both programs were dropped from the analyses.  15 
Peripheral Muscle Training (PMT) consisted of ten isotonic resistance exercises, 12 16 
repetitions for each one, completing the maximum mobility at a slow speed, working both 17 
concentric and eccentric phases and with two minutes recovery time between them. 18 
Resistance exercises were performed with a workload adjusted to 40- 60% of maximal 19 
isometric muscles strength (Kg), except when participants did not complete the maximum 20 
mobility, in which case the workload was reduced. Exercises were performed with dumbbells 21 
and ankle/wrist weights: four lower limb exercises (ankle flexion/extension, knee extension, 22 
and hip flexion/abduction/adduction) and six upper limb exercises (handgrip, wrist 23 
flexion/extension, forearm pronation/supination, elbow flexion/extension, and shoulder 24 
flexion/extension/adduction/abduction).  25 
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Respiratory Muscle Training (RMT) was carried out using a Threshold Inspiratory Muscle 1 
Trainer device (Respironics® Health Scan Inc. Cedar Grove, NJ, USA) with working range of 2 
7–41 cmH2O. An interval-based Inspiratory Muscle training program was performed 3 
consisting of seven 2-minute cycles of loaded breathing interspersed with a 1 minute period of 4 
rest between cycles (Hill, Cecins, Eastwood & Jenkins, 2010). The workload was adjusted to  5 
40-60% of MIP (cmH2O), except when participants did not complete the interval-training 6 
program, in which case the workload was reduced.  The physiotherapists monitored the 7 
participants throughout the training session with a pulse oximeter (SpO2 and heart frequency). 8 
In this way, each participant adopted their own and comfortable respiratory rate, avoiding 9 
undesirable desaturations and/or heart rate increases, as well as the occurrence of symptoms 10 
due to hyperventilation.  11 
Statistical Analyses 12 
A priori sample size calculations were obtained with the statistical program G*power 13 
3.1 (Faul, Erdfelder, Lang & Buchner, 2007), with an expected effect size (f) from medium to 14 
large, alfa of .05 and statistical power of .80. This resulted in an a priori total sample size of 15 
72 participants, or 24 per group. 16 
Analyses were conducted using the statistical software Statgraphics Centurion XVI.II. 17 
All data were checked for outliers, normal distributions (Shapiro-Wilk test), and homogeneity 18 
of variance (Levene’s test).  19 
Descriptive statistics were conducted for all variables at pre-intervention (T2). 20 
Moreover, pre-intervention differences of the variables between groups were examined to test 21 
whether any clinical or anthropometric variable could be included as a covariate in the 22 
analysis of variance (ANOVA). For this purpose, one-way ANOVA was conducted for all 23 
continuous variables and chi-square tests were used for categorical variables.  24 
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Treatment effects between the three groups (PMTG, RMTG, CG) were determined using one-1 
way ANOVA on change from pre-intervention, defined as post-intervention (T3) minus pre-2 
intervention (T2) values for each variable. Change analysis was used to offset possible 3 
differences of participants at pre-intervention and to minimize group data variability. Within-4 
group differences were assessed using paired t tests to compare mean change values. 5 
Between-group differences were calculated using a three-way ANOVA with group 6 
cardiovascular disease and endocrine disease as factors. Cardiovascular disease and endocrine 7 
disease were included as (categorical) covariates to eliminate the variability attributable to 8 
these variables. Post-hoc analyses were performed using Tukey’s highly significant difference 9 
test when a significant effect was found. Statistical significance was set at p < .05 for all tests.   10 
Results 11 
Participants 12 
The analyzed sample was made up of 37 older adults. The flow diagram (Figure 1) 13 
shows 44 drop-outs, the main reasons being: deaths, exacerbations, attendance less than 80% 14 
of sessions in trained groups, and withdraws (i.e. changing to another nursing home, falls, 15 
personal reasons and complaints). Deaths during the study development were as a result of the 16 
participants’ illnesses, and not from factors related to the measurements and/or training 17 
programs. Main complaints reported by participants occurred within the first two weeks of 18 
training and the most common were: difficulty in keeping the lips constrained in the 19 
mouthpieces of IMT device and nasal discomfort from nose clip placement during the session, 20 
in the RMTG; mild muscular discomfort and generalized fatigue that disappeared between 21 
sessions, in the PMTG. 22 
Descriptive 23 
Baseline characteristics 24 
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Pre-intervention characteristics of the three groups are presented in Table 1. Initially, 1 
the three groups did not show differences, except for cardiovascular (p = 0.02) and endocrine 2 
(p = .04) diseases. PMTG participants presented a higher number of cardiovascular and 3 
endocrine dysfunctions in comparison with the other two groups.  4 
INSERT TABLE 1 ABOUT HERE 5 
Effects of the training programs 6 
Results from the within-group and the between-group effects over the main outcomes 7 
are summarized in Table 2. No effects were found from endocrine and cardiovascular disease 8 
in any variables between pre and post-intervention in the three groups. 9 
INSERT TABLE 2 ABOUT HERE 10 
Skeletal Muscle Mass 11 
No significant changes were detected in any of the skeletal muscle mass measures 12 
(ASM /height2, ASM/weight and ASM/BMI) between pre and post-intervention in the three 13 
groups. 14 
Peripheral Muscle Strength 15 
A significant decrease occurred from pre to post-intervention in CG for Quadriceps 16 
Femoris (13.1%; t(11) = -2.33; p = .040) and Biceps Brachii (23.8%; t(11) = -2.84; p = .016). 17 
Nevertheless, results for the PMTG showed a significant increase in Quadriceps Femoris 18 
(51.9%; t(6) = 3.66; p = .011) and Biceps Brachii (17.4%; t(7) = 2.40; p = .048). For the 19 
RMTG, Quadriceps Femoris showed an increasing trend (9.1%; t(7) = .18; p = .859) while 20 
Biceps Brachii showed a significant decrease (16.7%; t(8) = -2.34; p = .048).  21 
Moreover, significant differences in peripheral muscle strength between groups were also 22 
observed for both Quadriceps Femoris (p = .009) and Biceps Brachii (p = .003). Post hoc 23 
analysis for Quadriceps Femoris strength showed that increases were greater in PMTG than 24 
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for CG participants. For Biceps Brachii strength, changes for the PMTG were greater than 1 
changes for the other two groups.  2 
No significant changes were seen in dominant handgrip strength values between pre 3 
and post-intervention. The same effects were detected for handgrip strength predicted values. 4 
Respiratory Muscle Strength 5 
The within-group ANOVA revealed significant differences in MIP and MEP values 6 
for CG between pre and post-intervention. CG subjects decreased their MIP and MEP with a 7 
mean of 8.2% (t(12) = -2.62, p = .022) and 15.6% (t(12) = -2.32, p = .039), respectively. 8 
PMTG showed a nonsignificant ascending trend of 13.5% in MIP (t(8) = 1.86, p = .100) and 9 
of  3.9% in MEP (t(8) = 0.63, p = .548). Likewise, changes from pre to post-intervention in 10 
these variables for RMTG were also found to be statistically nonsignificant.   11 
ANOVA comparisons between groups revealed significant differences for MIP (p = .007) and 12 
MEP (p = .040). Post hoc analysis showed greater changes for PMTG and RMTG compared 13 
to CG.   14 
Similar effects were detected for MIP and MEP predicted values. 15 
Respiratory Muscle Endurance 16 
Changes in MVV were statistically significant in the CG (t(12) = -3.22, p = .007), 17 
showing a 19.6% reduction from pre to post-intervention, while no significant changes were 18 
detected for both intervention groups (RMTG and PMTG). However, ascending trend values 19 
of 8.8% were seen for MVV in the PMTG (t(8) = 1.80, p = .110). 20 
Between-group ANOVA showed significant differences for MVV (p = .020). Post hoc 21 
analysis showed that changes in MVV for the PMTG and RMTG were greater than changes 22 
in the CG.   23 
Physical Performance 24 
Gait speed remained unchanged from pre to post-intervention in the three groups.  25 
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Training load 1 
Training loads in RMTG (Table 3) significantly improved during the training sessions both 2 
for absolute values (F11,220 = 130.2, p < .001, 2 = .867) and the percentages (F11,220 = 33.3, p 3 
< .001, 2 = .625).  Similar findings were obtained for PMTG (Table 3) in Biceps Brachii 4 
(absolute values F11,55 = 14.9, p = .005, 2 = .749; percentages F11,55 = 19.7, p = .002, 2 = 5 
0.797) and Quadriceps Femoris (absolute values F11,44 = 50.6, p < .001, 2 = .927; 6 
percentages F11,44 = 41.0, p < .001, 2 = .911). 7 
Discussion 8 
This study revealed that resistance training mainly improved the skeletal muscle 9 
strength in institutionalized older people, while there were no significant changes in physical 10 
performance and muscle mass for both training groups. Therefore, the most relevant finding 11 
of this study remained in counteracting the loss of muscle strength in this population. This 12 
result suggests that muscle strength was more sensitive to change, which declines 13 
significantly in the Control Group throughout the 3-month intervention. The improvement in 14 
muscle strength is more remarkable in the peripheral muscles (where there is a significant 15 
increase in the specifically trained group) than in the respiratory ones. Moreover, there was no 16 
evidence to suggest that one specific muscle mass index (ASM/heigth2, ASM/weight and 17 
ASM/BMI) was more appropriate than another when assessing the effects of the 3-month 18 
resistance training. 19 
These results, as stated in a recent systematic review about sarcopenia by Cruf-Jentoft 20 
et al. (2014), reinforce the need to perform peripheral muscle resistance training in older 21 
adults. For example, Binder et al. (2005) obtained an improvement in voluntary knee-22 
extension force through progressive resistance training in frail older adults living in the 23 
community. In our study, the peripheral muscle strength was assessed by maximal isometric 24 
Quadriceps Femoris and Biceps Brachii strength and also showed an improvement, while 25 
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there was no significant effect seen in handgrip strength. In this respect, a recent pilot study 1 
implemented in nursing home participants (Hassan et al., 2016) demonstrated an 2 
improvement in muscle strength (dominant handgrip measurement) as a consequence of a 3 
longer period of intervention (six months), including balance training. Tieland et al. (2015) 4 
doubt if handgrip is a good measurement to detect changes in muscle strength derived from 5 
resistance training in frail older people because measurements could vary depending on age, 6 
sex and nutrition, as also pointed out by Budziareck, Roig, & Barbosa (2008). In the present 7 
study, the improvement in Quadriceps Femoris and Biceps Brachii strength was important for 8 
two reasons; firstly, because there was a substantial reversion of the muscle strength loss in 9 
Control Group, and secondly because there was a significant increase in the peripheral trained 10 
group. 11 
The present study demonstrated nonsignificant improvement in RM functioning in the 12 
RMTG. However, when compared with the CG values, it showed a significant improvement. 13 
This result suggests that respiratory muscle training has a preventive function as RM values 14 
were maintained in institutionalized older adults with sarcopenia. This is relevant, bearing in 15 
mind the high prevalence of RM strength decline in this group of the population (Simões, 16 
Castello, Auad, Dionísio & Mazzonetto, 2009; Simões, Dias, Marinho, Pinto & Britto, 2010). 17 
According to Bahat and colleagues (2014), the decline affects more inspiratory than 18 
expiratory muscle strength in sarcopenic older adults. Another explanation for this 19 
nonsignificant improvement in RM functioning in the trained group could be the short 20 
program duration or amount of sessions (Cebrià i Iranzo, Arnall, Igual Camacho, Tomás & 21 
Meléndez, 2013). Despite following recommendations for an Inspiratory Muscle Training 22 
program (intensity, frequency and duration) for Chronic Obstructive Pulmonary patients 23 
proposed by Hill, Cecins, Eastwood & Jenkins (2010) and Gosselink et al. (2011), these have 24 
been insufficient for the characteristics of our study population. Moreover, Current 25 
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recommendations for resistance training in sarcopenic older adults (Cruz-Jentoft et al., 2014) 1 
point out that the time of intervention should be at least 3 months. 2 
As it has been commented in the Results section, the rise in the training load was 3 
observed both for the inspiratory muscle strength (MIP) and for peripheral muscle strength 4 
(maximal isometric muscle strength of Biceps Brachii and Quadriceps Femoris). This shows 5 
that the intensity of training increased progressively. Moreover, this increase has exceeded the 6 
percentage of load that has been considered high enough to achieve the training adaptations.  7 
Although the planning contemplated training at loads between 40 and 60%, the participants 8 
trained with the load they were able to lift.  9 
The current study revealed a maintenance of gait speed after training, as was also 10 
demonstrated in the study carried out by Hassan et al. (2016). A possible explanation could be 11 
that our training program did not include specific exercises to improve mobility, such as 12 
aerobic training and balance reeducation. These authors combine resistance and balance 13 
training without obtaining significant gain in the gait speed. Nevertheless, there was an 14 
improvement in standing capacity.  15 
As mentioned above, the evolution of the muscle mass indexes along time (pre-post-16 
intervention) was similar in both the control group and the trained ones. That is, it remained 17 
relatively stable for all three groups. In this respect, a pilot study implemented in nursing 18 
home participants also obtained similar results (Hassan et al., 2016). Though the result in 19 
muscle mass after training was unexpected, the improvement of muscle strength is a positive 20 
result because this could help prevent disability in institutionalized older adults.  Ivey et al. 21 
(2000) and Hassan et al. (2016) suggest that the resistance training might induce functional 22 
(consequence of neural and/or metabolic muscle responses) versus structural (muscle cross 23 
sectional area) adaptations. 24 
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Sarcopenia is related to factors such as comorbidity, mobility disorders and 1 
malnutrition, thus experts (EWGSOP, IWGSP, AWGSP y el FNIH) recommend combining 2 
exercise and nutrition interventions. Recent literature reviews (Denison, Cooper, Sayer & 3 
Robinson, 2015; Yu, Khow, Jadczak & Visvanathan, 2016) highlight inconsistent results 4 
mainly due to heterogeneity of population (age, sex, anthropometrics, settings, etc.) and 5 
intervention characteristics (resistance versus aerobic, diversity in nutrition supplementation, 6 
etc.). The majority of published trial findings were carried out on healthy older adults living 7 
in the community (Bell et al., 2017) and in sarcopenic older adults (Rondanelly et al., 2016). 8 
In settings such as nursing homes or hospitals there is still a lack of these combined 9 
interventions (Bauer, Kaiser & Sieber, 2008), and their results are also inconsistent (Carlsson 10 
et al., 2011).  11 
The EWGSOP (Cruz-Jentoft et al., 2010) define sarcopenia as low muscle mass and 12 
/or both low muscle strength and low gait. Nowadays, there is an important debate on muscle 13 
mass cut-off (Pagotto y Silveira, 2014; Studensky et al., 2014; Moon et al., 2016), arguing 14 
that they should be considered and adapted to older population characteristics and settings 15 
(Tyrovolas et al., 2015; Meng et al., 2015; Kim, Jang & Lim, 2016), in order to avoid the 16 
infra-diagnostic of sarcopenia. For this reason, our study has included different muscle mass 17 
parameters (ASM/height2; ASM/weight; ASM/BMI) as proposed by Tyrovolas et al., (2015). 18 
With regards to the characteristics of our studied population (Spanish, institutionalized and 19 
obese, BMI > 30 Kg/m2), we considered the appropriate parameters to be those related to 20 
weight (ASM/weight; ASM/BMI) instead of the one usually applied (ASM/height2). We 21 
assessed which of these parameters was more sensitive for showing an improvement after 22 
resistance training in sarcopenic institutionalized older adults, and the findings were unclear 23 
because all parameters behaved similarly.   24 
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Our study has several limitations. The analyzed sample diminishes considerably with 1 
respect to the participants’ characteristics (Table 1) such as high comorbidity and advanced 2 
age (Mage > 80 years), functional impairment and whether they live in a nursing home. This 3 
lost in the follow-up is common in other nursing home research studies (Mody et al., 2008; 4 
Hassan et al., 2016).  We consider only the sarcopenia status for inclusion criteria and 5 
outcomes rather than the Fragility status, which contemplates additional functional 6 
parameters. We did not include follow-up of maintenance of resistance training effects. 7 
Despite ASM being a variable used infrequently in previous clinical trials, which makes it 8 
difficult to make direct comparison with our trial, we decided to use ASM indexes proposed 9 
by Tyrovolas et al. (2015) which are specific cut-offs for Spanish population. Furthermore, 10 
ASM might be more appropriate for detecting possible changes in upper and lower limbs 11 
muscles. Finally, this trial did not collect physical activity as outcome. 12 
 Nonetheless, this study has some distinctive strengths. We compared two resistance 13 
training protocols: One in respiratory muscles and one in peripheral muscles, both skeletal 14 
muscles affected by sarcopenia syndrome. Following the current international debate on 15 
reviewing the definition of sarcopenia, we have used the criteria of Tyrovolas et al. (2015) for 16 
muscle mass measurement (ASM/BMI) specific for older Spanish people. Finally, as a 17 
relevant clinical finding, the improvement of muscle strength may be associated to a lower 18 
risk of mortality, as suggested by Newman and colleagues (2006). In this line, the 19 
improvement of peripheral muscle strength, as well as the absence of loss of this in the 20 
respiratory musculature in our study, may lead to a lower risk of mortality. 21 
Mainly this clinical trial shows an improvement in the skeletal muscle strength in 22 
institutionalized older adults with sarcopenia. This benefit can be extended to the older 23 
population with sarcopenia, both at the community and nursing homes. To achieve this, health 24 
professionals’ collaboration might be necessary in order to inform, encourage and supervise 25 
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the training programs (health promotion programs in primary care and the improvement of 1 
rehabilitation programs in nursing homes). 2 
Conclusion 3 
This resistance training has demonstrated an improvement in skeletal muscle strength 4 
(MR and MP) in institutionalized older adults with sarcopenia, indicating its preventive 5 
character and the potential benefit in carrying out the training in presarcopenic 6 
institutionalized older adults. However, there was no significant improvement in muscle mass, 7 
in spite of measuring it through different parameters to avoid sarcopenia infra-diagnosis and 8 
detect the training effects appropriately. Consequently, there are two fundamental 9 
considerations rising from this study: Firstly, the necessity to adapt the physical exercise 10 
program by taking into account the specificity of the population and the desired functional 11 
outcome (improvement in muscle strength, walking speed, transfers, etc.); secondly, to 12 
combine physical exercise intervention with nutritional supplementation. 13 
Finally, regarding the debate around cut-offs, this study does not clarify which muscle mass 14 
parameter is the appropriate for detecting changes after physical interventions. As a result, the 15 
discussion continues on how to propose interventions and how to measure their effects on 16 
sarcopenia in the institutionalized older adult population. 17 
18 
RESISTANCE TRAINING IN SARCOPENIC OLDER ADULTS  20
References 1 
ATS/ERS (2002). Statement on respiratory muscle testing. American Journal of Respiratory 2 
and Critical Care Medicine, 166, 518-624. 3 
Bahat, G., Tufan, A., Ozkaya, H., Tufan, F., Akpinar, T.S., Akin, S., & Karan, M.A. (2014). 4 
Relation between hand grip strength, respiratory muscle strength and spirometric 5 
measures in male nursing home participants. The Aging Male, 17, 136-140. 6 
Bauer, J.M., Kaiser, M.J., & Sieber, C.C. (2008). Sarcopenia in nursing home participants. 7 
Journal of American Medical Directors Association, 9, 545-51. 8 
Bean, J.F., Kiely, D.K., Herman, S., Leveille, S.G., Mizer, K., Frontera, W.R., Fielding, R.A. 9 
(2002). The relationship between leg power and physical performance in mobility-limited 10 
older people. Journal of American Geriatric Society, 50, 461–7. 11 
Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J.Y. & Bruyère, O. (2017). Health Outcomes 12 
of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS ONE, 12, e0169548. 13 
doi:10.1371/journal.pone.0169548 14 
Bell, K.E., Snijders, T., Zulyniak, M., Kumbhare, D., Parise, G., Chabowski, A., & Phillips, 15 
S.M. (2017). A whey protein-based multi-ingredient nutritional supplement stimulates 16 
gains in lean body mass and strength in healthy older men: A randomized controlled trial. 17 
PLoS One, 12, e0181387. doi: 10.1371/journal.pone.0181387.  18 
Black, L.F., & Hyatt, R.E. (1969). Maximal respiratory Pressures: normal values and 19 
relationship to age and sex. The American review of respiratory disease, 99, 696-702. 20 
Binder, E.F., Yarasheski, K.E., Steger-May, K., Sinacore, D.R., Brown, M., Schechtman, 21 
K.B., & Holloszy, J.O. (2005). Effects of progressive resistance training on body 22 
composition in frail older adults: results of a randomized, controlled trial. Journal of 23 
Gerontology. A Biological Science and Medicine Sciences, 60, 1425-31. 24 
RESISTANCE TRAINING IN SARCOPENIC OLDER ADULTS  21
Borg, G. (2004). The Borg CR10 Scale Folder. A method for measuring intensity of 1 
experience. Hasselby, Sweden: Borg Perception. 2 
Budziareck, M.B., Roig, R. & Barbosa, P. (2008). Reference values and determinants for 3 
handgrip strength in healthy subjects. Clinical Nutrition, 27, 357-362. 4 
Carlsson, M., Littbrand, H., Gustafson, Y., Lundin-Olsson, L., Lindelöf, N., Rosendahl, E., 5 
Håglin, L. (2011). Effects of high-intensity exercise and protein supplement on muscle 6 
mass in ADL dependent older people with and without malnutrition: a randomized 7 
controlled trial. Journal of Nutrition and Health Aging, 15, 554-60. 8 
Cebrià i Iranzo, M.A., Arnall, D.A., Igual Camacho, C., Tomás J.M and Meléndez, J.C. 9 
(2013). Intervención fisioterápica preventiva del deterioro de la musculatura respiratoria 10 
en ancianas institucionalizadas con limitación funcional. Archivos de Bronconeumología, 11 
49, 1–9. 12 
Chen, K.K., Liu, L.K., Woo, J., Assantachai, P., Auyeung. T.W., Bahyah, K.S.and Suzuki, T. 13 
(2014). Sarcopenia in Asia: Consensus Report of the Asian Working Group for 14 
Sarcopenia. Journal of the American Medical Directors Association, 15, 95–101.  15 
Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M. Boirie, Y., Cederholm, T., Landi, F. and 16 
Zamboni, M. European Working Group on Sarcopenia in Older People. (2010). 17 
Sarcopenia: European consensus on definition and diagnosis: report of the European 18 
Working Group on Sarcopenia in Older People. Age and Ageing, 39, 412–23.  19 
Cruz-Jentoft A.J., Triana F.C., Gómez-Cabrera M.C., López-Soto A., Masanés F., Martín 20 
P.M., & Formiga F. (2011). The emergent role of sarcopenia: Preliminary Report of the 21 
Observatory of Sarcopenia of the Spanish Society of Geriatrics and Gerontology. Revista 22 
Española de Geriatría y Gerontología, 46, 100-10. 23 
Cruz-Jentoft, A.J., Landi, F., Schneider, S.M., Zúñiga, C., Arai, H., Boirie, Y., and 24 
Cederholm, T. (2014). Prevalence of and interventions for Sarcopenia in ageing adults: a 25 
RESISTANCE TRAINING IN SARCOPENIC OLDER ADULTS  22
systematic review: report of the International Sarcopenia Initiative (EWGSOP and 1 
IWGS). Age and Ageing, 43, 748–59. 2 
Denison, H.J., Cooper, C., Sayer, A.A. & Robinson S.M., (2015). Prevention and optimal 3 
management of Sarcopenia: a review of combined exercise and nutrition interventions to 4 
improve muscle outcomes in older people. Clinical Interventions in Aging, 10, 859–869. 5 
Enright, P.L., Kronmal, R.A., Manolio, T.A., Schenker, M.B. & Hyatt, R.E. for the 6 
Cardiovascular Health Study Research Group. (1994). Respiratory Muscle Strength in the 7 
older adult. Correlates and references values. American Journal of Respiratory Critical 8 
Care Medicine, 149, 430-438. 9 
Ethgen, O., Beaudart, C., Buekinx, F., Bruyere, O. & Reginster, J.Y. (2016). The Future 10 
Prevalence of Sarcopenia in Europe: A Claim for Public Health Action. California Tissue 11 
International, 100, 229-234. 12 
Faul, F., Erdfelder, E., Lang, A.G., & Buchner, A. (2007). G*Power 3: A flexible statistical 13 
power analysis program for the social, behavioral, and biomedical sciences. Behavior 14 
Research Methods, 39, 175-191. 15 
Gosselink, R., De Vos, J., van den Heuvel, S.P., Segers, J., Decramer, M. & Kwakkel, G. 16 
(2011). Impact of inspiratory muscle training in patients with COPD: what is the 17 
evidence? European Respiratory Journal, 37, 416-25. 18 
Hassan, B.H, Hewitt, J., Keogh, J.W., Bermeo, S., Duque, G. & Henwood, T.R. (2016). 19 
Impact of resistance training on Sarcopenia in nursing care facilities. A pilot study. 20 
Geriatric Nursing, 37, 116-121.    21 
Henwood, T.R., Keogh, J.W., Reid, N., Jordan, W. & Senior, H.E. (2014). Assessing 22 
sarcopenic prevalence and risk factors in residential aged care: methodology and 23 
feasibility. Journal of Cachexia, Sarcopenia and Muscle, 5, 229–236.  24 
RESISTANCE TRAINING IN SARCOPENIC OLDER ADULTS  23
Hill, K., Cecins, N.M., Eastwood, P.R. & Jenkins, S.C. (2010). Inspiratory muscle training for 1 
patients with chronic obstructive pulmonary disease: A practical guide for clinicians. 2 
Archives of Physical Medicine and Rehabilitation, 91, 1466-70. 3 
Ivey, F.M., Tracy, B.L., Lemmer, J.T., NessAiver, M., Metter, E.J., Fozard, J.L. & Hurley, 4 
B.F. (2000). Effects of strength training and detraining on muscle quality: age and gender 5 
comparisons. Journal of Gerontology. A Biological Science and Medicine Sciences,55, 6 
B152-7; discussion B158-9. 7 
Kim, K.M., Jang, H.C. & Lim, S. (2016). Differences among skeletal muscle mass indices 8 
derived from height-, weight-, and body mass index-adjusted models in assessing 9 
Sarcopenia. Korean Journal of Internal Medicine, 31, 643-650.  10 
Landi, F., Liperoti, R., Fusco, D., Mastropaolo, S., Quattrociocchi, D., Proia, A. & Onder, G. 11 
(2012). Pre-valence and risk factors of Sarcopenia among nursing home older residents. 12 
Journals of Gerontology. A Biological Science and Medicine Science, 67A, 48–55.  13 
Lobo, A., Saz, P. & Marcos, G. (2002). Adaptación del examen cognoscitivo Mini-Mental. 14 
Madrid: TA ediciones. 15 
Luna-Heredia, E., Martín-Peña, G. & Ruiz-Galiana, J. (2005). Handgrip dynamometry in 16 
healthy adults. Clinical Nutrition, 24, 250-258. 17 
Meng, N.H., Li, C.I., Liu, C.S., Lin, W.Y., Lin, C.H., Chang, C.K. & Lin, C.C. (2015). 18 
Sarcopenia Defined by Combining Height-and Weigth-Adjusted Skeletal Muscle Indices 19 
is Closely Associated With Poor Physical Performance. Journal of Aging and Physical 20 
Activity, 23, 597-606. 21 
Mody, L., Miller, D.K., McGloin, J.M., Freeman, M., Marcantonio, E.R., Magaziner, J. & 22 
Studenski, S. (2008). Recruitment and retention of older adults in aging research. Journal 23 
of American Geriatrics Society, 56, 2340-2348. 24 
RESISTANCE TRAINING IN SARCOPENIC OLDER ADULTS  24
Moon, J.H., Kim, K.M., Kim, J.H., Moon, J.H., Choi, S.H., Lim, S. & Jang, H.C. (2016). 1 
Predictive Values of the New Sarcopenia Index by the Foundation for the National 2 
Institutes of Health Sarcopenia Project for Mortality among Older Korean Adults. PLoS 3 
ONE, 11, 11, e0166344. doi:10.1371/journal.pone.0166344 4 
Neder, J.A., Andreoni, S., Lerario, M.C. & Nery, L.E. (1999). Reference values for lung 5 
function tests. II. Maximal respiratory pressures and voluntary ventilation.  Brazilian 6 
Journal of Medical and Biological Research, 32, 719-727. 7 
Newman, A.B., Kupelian, V., Visser, M., Simonsick, E., Goodpaster, B., Nevitt, M. & Harris, 8 
T.B. (2003).  Health ABC Study Investigators. Sarcopenia: alternative definitions and 9 
associations with lower extremity function. Journal of American Geriatrics Society, 51, 10 
1602-1609. 11 
Newman, A.B., Kupelian, V., Visser, M., Simonsick, E.M., Goodpaster, B.H., Kritchevsky, 12 
S.B., & Harris, T.B. (2006). Strength, but not muscle mass, is associated with mortality in 13 
the health, aging and body composition study cohort. Journal Gerontology: Medical 14 
Science, 61,72-77. 15 
NIH. (1996). Bioelectrical impedance analysis in body composition measurement: National 16 
Institutes of Health Technology Assessment Conference Statement. American Journal of 17 
Clinical Nutrition, 64, 524S–532S. 18 
Pagotto, V. & Silveira, E.A. (2014). Methods, diagnostic criteria, cutoff points, and 19 
prevalence of Sarcopenia among older people. Scientific World Journal, 231312.  20 
Rondanelli, M., Klersy, C., Terracol, G., Talluri, J., Maugeri, R., Guido, D. & Perna, S. 21 
(2016). Whey protein, amino acids, and vitamin D supplementation with physical activity 22 
increases fat-free mass and strength, functionality, and quality of life and decreases 23 
inflammation in sarcopenic older adult. American Journal of Clinical Nutrition, 103, 830-24 
840. 25 
RESISTANCE TRAINING IN SARCOPENIC OLDER ADULTS  25
Rubbieri, G., Mossello, E., & Di Bari, M. (2014). Techniques for the diagnosis of sarcopenia. 1 
Clinical Cases Mineral Bone Metabolism, 11, 181-184. 2 
Salvà, A., Serra-Rexach, J. A., Artazad, I., Formigae, F., Rojano X., Cuestaf, F. & Cruz-3 
Jentoftl, A.J. (2016). La prevalencia de Sarcopenia en residencias de España: 4 
comparación de los resultados del estudio multicéntrico ELLI con otras poblaciones. 5 
Revista Española Geriatría y Gerontología, 51, 260–264. 6 
Simões, R.P., Castello, V., Auad, M.A., Dionísio, J. & Mazzonetto, M. (2009). Prevalence of 7 
reduced respiratory muscle strength in institutionalized older adult people. Sao Paulo 8 
Medical Journal, 127, 78-83.  9 
Simões, L.A., Dias, J.M., Marinho, K.C., Pinto, C.L. & Britto, R.R. (2010). Relationship 10 
between functional capacity assessed by walking test and respiratory and lower limb 11 
muscle function in community-dwelling elders. Revista Brasileira De Fisioterapia, 14, 12 
24-30. 13 
Studenski, S.A., Peters, K.W., Alley, D.E., Cawthon, P.M., McLean, R.R., Harris, T.B. & 14 
Vassileva, M.T. (2014). The FNIH Sarcopenia project: rationale, study description, 15 
conference recommendations, and final estimates. Journals of Gerontology. A Biological 16 
Science and Medicine Science, 69, 547–58.  17 
Tilson, J.K., Sullivan, K.J., Cen, S.Y., Rose, D.K., Koradia, C.H., Azen, S.P. & Duncan, P.W. 18 
Locomotor Experience Applied Post Stroke (LEAPS) Investigative Team. (2010) 19 
Meaningful gait speed improvement during the first 60 days poststroke: minimal 20 
clinically important difference. Physical Therapy, 90, 196-208. 21 
Tieland, M., Verdijk, L.B., de Groot, L.C. & van Loon, L.J. (2015). Handgrip Strength Does 22 
Not Represent an Appropriate Measure to Evaluate Changes in Muscle Strength During 23 
an Exercise Intervention Program in Frail Older People. International Journal of Sport 24 
Nutrition and Exercise Metabolism, 25, 27-36. 25 
RESISTANCE TRAINING IN SARCOPENIC OLDER ADULTS  26
Tyrovolas, S., Koyanagi, A., Olaya, B., Ayuso-Mateos, J.L., Miret, M., Chatterji, S. & Haro, 1 
J.M. (2015). The role of muscle mass and body fat on disability among older adults: A 2 
cross-national analysis. Experimental Gerontology, 69, 27–35.   3 
Yu, S.C., Khow K.S., Jadczak, A.D. & Visvanathan, R. (2016). Clinical Screening Tools for 4 
Sarcopenia and Its Management. Current Gerontology and Geriatrics Research, 5 
5978523. doi: 10.1155/2016/5978523. 6 
Wei-Ju, L., Li-Kuo, L., Li-Ning, P., Ming-Hsien, L., Liang-Kung, C. & ILAS Research 7 
Group (2013). Comparisons of Sarcopenia Defined by IWGS and EWGSOP Criteria 8 
Among Older People: Results From the I-Lan Longitudinal Aging Study. Journal of the 9 
American Medical Directors Association, 14, 528.e1–528.e7.  10 
